Keeping out counterfeit drugs: policies to protect patients

While the U.S. House and Senate overwhelmingly passed legislation (H.R.

5651, S. 3187) to fund the U.S. Food and Administration's drug safety and review efforts last month, an important question remains: Will Congress include a strong national system to track drugs? To address this challenge, the Pew Health Group is hosting a policy forum, "Keeping Out Counterfeit Drugs" on Wednesday, June 6. A panel of experts on pharmaceutical distribution technology will discuss the elements of a national system to secure drug distribution and protect patients from counterfeit and unsafe medicines. They also will examine existing practical and feasible ways to track each bottle of pills and vial of medicine and verify its authenticity before reaching patients.

WHO: Panelists include:

Kimberly Fleming, senior manager, Product Security, EMD
Serono
Glenn Siegele, president, Omega Design; member of the
board, Packaging Machinery Manufacturers Institute
Walter Berghahn, president, SmartRmeds for Life; executive
director, Healthcare Compliance Packaging Council
William Fletcher, managing partner, Pharma Logic
Solutions, LLC.

Allan Coukell, a pharmacist and director of medical
programs at the Pew Health Group, will moderate the panel
discussion.

WHEN: Wednesday, June 6, 2012
1:30 p.m. - 2:30 p.m.
Doors open at 1:15 p.m.

WHERE: U.S. Capitol
Room SC-6

RSVP: Please RSVP to Linda Paris by Tuesday, June 5, 2012
Companies in this article
More in Home